These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 334416)

  • 21. Incidence of leukaemia in patients with primary myelofibrosis and RBC-transfusion-dependence.
    Passamonti F; Rumi E; Elena C; Arcaini L; Merli M; Pascutto C; Cazzola M; Lazzarino M
    Br J Haematol; 2010 Sep; 150(6):719-21. PubMed ID: 20560961
    [No Abstract]   [Full Text] [Related]  

  • 22. [Nosology and diagnosis of myeloproliferative syndrome].
    Zittoun R; Bernadou A; Zittoun J; Fretault J; Bousser J
    Sem Hop; 1968 Jun; 44(31):2079-84. PubMed ID: 4300452
    [No Abstract]   [Full Text] [Related]  

  • 23. [Transformation of a myelodysplastic to a myeloproliferative syndrome (chronic granulocytic leukemia)].
    Seewann HL
    Wien Klin Wochenschr; 1985 Mar; 97(7):320-2. PubMed ID: 3857790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetics of proliferation and differentiation of human hemopoietic cells in a diffusion chamber system.
    Chikkappa G; Carsten AL; Cronkite EP
    Exp Hematol; 1980 May; 8(5):533-40. PubMed ID: 6936262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased risk of myeloid leukaemia in patients with ankylosing spondylitis following treatment with radium-224.
    Wick RR; Nekolla EA; Gaubitz M; Schulte TL
    Rheumatology (Oxford); 2008 Jun; 47(6):855-9. PubMed ID: 18390588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myeloid leukaemia in x-ray irradiated CBA mice.
    Major IR; Mole RH
    Nature; 1978 Mar; 272(5652):455-6. PubMed ID: 273147
    [No Abstract]   [Full Text] [Related]  

  • 27. Aberrant expression of beta-catenin discriminates acute myeloid leukaemia from acute lymphoblastic leukaemia.
    Serinsöz E; Neusch M; Büsche G; Wasielewski R; Kreipe H; Bock O
    Br J Haematol; 2004 Aug; 126(3):313-9. PubMed ID: 15257703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The induction by 224Ra of myeloid leukaemia and osteosarcoma in male CBA mice.
    Humphreys ER; Loutit JF; Major IR; Stones VA
    Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Mar; 47(3):239-47. PubMed ID: 3872276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Familial myeloproliferative syndromes. Study of 6 families and review of literature].
    Kaufman S; Brière J; Bernard J
    Nouv Rev Fr Hematol (1978); 1978 Apr; 20(1):1-15. PubMed ID: 353725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Editorial: Radiation and leukaemia.
    Med J Aust; 1974 Dec; 2(25):891-2. PubMed ID: 4532715
    [No Abstract]   [Full Text] [Related]  

  • 31. Antigenic phenotype of myelomonocytic progenitors (CFU-GM) in chronic myeloproliferative disorders.
    Ferrero D; Tarella C; Pregno P; Pileri A; Gallo E
    Cancer Res; 1986 Feb; 46(2):975-80. PubMed ID: 3455679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical diagnostic X-ray irradiation and risk of leukemia in urban adult population of Poland. I. Design of the study.
    Gajewski AK; Rozycki Z; Słowikowska GM; Krzyzanowski M; Majle T
    Rocz Panstw Zakl Hig; 1988; 39(4):249-57. PubMed ID: 3238286
    [No Abstract]   [Full Text] [Related]  

  • 33. De novo appearance of der(1;7)(q10;p10) is associated with leukemic transformation and unfavorable prognosis in essential thrombocythemia.
    Hsiao HH; Ito Y; Sashida G; Ohyashiki JH; Ohyashiki K
    Leuk Res; 2005 Nov; 29(11):1247-52. PubMed ID: 16164981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnostic difficulties in osteomyelosclerosis with myeloid metaplasia in relation to the other components of the myeloproliferative syndrome].
    Vilcu A; Hossu T; Popescu ID; Câmpeanu L
    Med Interna (Bucur); 1973 Mar; 25(3):363-76. PubMed ID: 4527026
    [No Abstract]   [Full Text] [Related]  

  • 35. Plasma fibronectin in idiopathic myelofibrosis and related chronic myeloproliferative disorders.
    Hasselbalch H; Clemmensen I
    Scand J Clin Lab Invest; 1987 Sep; 47(5):429-33. PubMed ID: 3477850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogeny of the blastic transformations in chronic granulocytic leukemia.
    Popa G; Ungureanu E
    Rev Med Chir Soc Med Nat Iasi; 1985; 89(4):683-5. PubMed ID: 3869738
    [No Abstract]   [Full Text] [Related]  

  • 37. Size and charge heterogeneity of amino acid naphthylamidase isozymes in normal and neoplastic granulocytic cells.
    Roos G; Emdin S; Lundgren E
    Leuk Res; 1980; 4(6):591-9. PubMed ID: 6937724
    [No Abstract]   [Full Text] [Related]  

  • 38. Myeloproliferative disorders terminating in acute micromegakaryoblastic leukaemia.
    Efrati P; Nir E; Yaari A; Berrebi A; Kaplan H; Dvilanski A
    Br J Haematol; 1979 Sep; 43(1):79-86. PubMed ID: 389275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carcinoma of the breast, chronic lymphocytic leukemia, macroglobulinemia, eosinophilic chloroma and myelosclerosis--a unique association.
    Benvenisti DS; DeBellis RH
    Cancer; 1969 May; 23(5):1204-9. PubMed ID: 4976031
    [No Abstract]   [Full Text] [Related]  

  • 40. Chronic granulocytic leukemia--selective removal of immature granulocytic cells by leukapheresis.
    Goldman JM; Lowenthal RM; Buskard NA; Spiers AS; Th'ng KH; Park DS
    Ser Haematol; 1975; 8(4):28-40. PubMed ID: 1087996
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.